Money Concepts Capital’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.53M Buy
123,261
+8,260
+7% +$391K 0.25% 89
2025
Q4
$5.85M Buy
115,001
+56,437
+96% +$2.89M 0.33% 64
2025
Q3
$3.25M Buy
58,564
+2,781
+5% +$163K 0.2% 107
2025
Q2
$3.85M Buy
55,783
+51,146
+1,103% +$3.48M 0.26% 85
2025
Q1
$322K Sell
4,637
-258
-5% -$21.3K 0.02% 343
2024
Q4
$421K Sell
4,895
-6,102
-55% -$660K 0.03% 312
2024
Q3
$1.31M Buy
10,997
+473
+4% +$63.1K 0.1% 183
2024
Q2
$1.5M Sell
10,524
-238
-2% -$31.5K 0.13% 166
2024
Q1
$1.38M Buy
10,762
+2,642
+33% +$315K 0.13% 185
2023
Q4
$840K Sell
8,120
-105
-1% -$10.4K 0.08% 215
2023
Q3
$748K Buy
8,225
+683
+9% +$60.2K 0.08% 215
2023
Q2
$610K Sell
7,542
-1,672
-18% -$137K 0.06% 237
2023
Q1
$730K Sell
9,214
-2,226
-19% -$158K 0.04% 256
2022
Q4
$774K Buy
11,440
+5,918
+107% +$347K 0.03% 342
2022
Q3
$275K Buy
5,522
+2,006
+57% +$107K 0.02% 377
2022
Q2
$196K Sell
3,516
-3,024
-46% -$168K 0.02% 419
2022
Q1
$363K Buy
6,540
+2,582
+65% +$133K 0.02% 524
2021
Q4
$222K Buy
+3,958
New +$214K 0.02% 465
2021
Q1
Sell
-6,152
Closed -$215K 750
2020
Q4
$215K Buy
+6,152
New +$213K 0.02% 400

Other funds holding NVO

Money Concepts Capital's NVO Position: Q1 2026 in Review

Money Concepts Capital increased its Novo Nordisk (NVO) stake by 7.2% in Q1 2026, buying an estimated $391K and bringing the position to 123,261 shares worth $4.53M. The position accounts for 0.25% of the portfolio, ranked #89.

Money Concepts Capital first reported a position in NVO in Q4 2020 and has held it in 19 quarters since. The position peaked at $5.85M in Q4 2025. 1,272 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Money Concepts Capital held 123,261 shares of Novo Nordisk worth $4.53M as of Q1 2026.
  • Money Concepts Capital bought 8,260 Novo Nordisk shares in Q1 2026, an estimated $391K.
  • Novo Nordisk made up 0.25% of Money Concepts Capital's portfolio in Q1 2026, its #89 holding.
  • Money Concepts Capital first reported a position in Novo Nordisk in Q4 2020 and has held it in 19 quarters since.
  • Money Concepts Capital's Novo Nordisk position peaked at $5.85M in Q4 2025.
  • 1,272 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Money Concepts Capital's 13F filing for Q1 2026, filed 30 Apr 2026.